Biosimilars have typically been viewed as cost-saving medications, but according to results of a study published in JAMA Health Forum, biosimilar competition did not consistently lower out-of-pocket costs for outpatients who were commercially insured. In fact, in some cases, costs even increased.

The New York State Department of Health issued an order in late March to formally implement a new law establishing access to hormonal contraception from pharmacists without a physician’s order.

High levels of the human carcinogen benzene can form in some acne treatment products containing benzoyl peroxide, according to a new report from the independent quality assurance laboratory Valisure. The company has launched a citizen petition urging FDA to take action on these products by encouraging an investigation and market withdrawal of the affected items.